At a glance
ClinicalIndex Comparison RecordStandardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Management of Severe Acute Malnutrition in Children With Sickle Cell Disease Greater Than 5 Years of Age Living in Northern Nigeria
In Brief
A Phase 2 clinical trial evaluating hydroxyurea (20mg/kg/day) and Ready-to-use therapeutic food for Sickle Cell Anemia and Severe Acute Malnutrition. Completed, enrolled 132 participants across 3 sites in 2 countries.
Detailed Summary
Except for children with HIV, all recommendations for treatment of childhood malnutrition are for children \< 5 years of age. The overall goal of this randomized controlled nutrition feasibility trial is to identify whether families of children with sickle cell disease (SCD) 5 years and older agree to participate over a 12-week period. The investigators will also establish a safety protocol for monitoring potential complications associated with treating severe malnutrition in children 5 years and older with and without SCD, in a low-resource setting.
Study Details
Timeline
Interventions
Treatment of severe malnutrition in children with SCA in northern Nigeria
Treatment of severe malnutrition in children with and without SCA in northern Nigeria with an additional 500-1000 calories from ready-to-use-therapeutic food